Previous 10 | Next 10 |
HealthEquity continues to grow, and it has demonstrated its ability to generate strong and growing cash flows over time. Long-term, the company will probably do quite well for investors, but this doesn't make it a great prospect. Shares are pricey and are, likely, fairly valued at...
Medicaid-focused health insurer, Molina Healthcare (NYSE:MOH), is expected to debut in the S&P 500 before the trading opens on March 02, it was announced last Friday. Long Beach, California-based company will replace IHS Markit Ltd (NYSE:INFO), which is on track to complete its buyout dea...
Molina Healthcare Set to Join S&P 500; Range Resources to Join S&P MidCap 400; Golden Entertainment to Join S&P SmallCap 600 Molina Healthcare Set to Join S&P 500; Range Resources to Join S&P MidCap 400; Golden Entertainment to Join S&P SmallCap 600 P...
Healthcare is relatively well-positioned as a defensive sector in a volatile market environment compared to the broader market. Favorable trends to continue boosting healthcare spending. Medical Services and Pharmaceuticals are a few that are better-positioned, while biotechs face...
Molina Healthcare, Inc. (MOH) Q4 2021 Earnings Conference Call February 10, 2022 08:00 AM ET Company Participants Joe Krocheski - Senior Vice President- Investor Relations Joe Zubretsky - President & Chief Executive Officer Mark Keim - Chief Financial Officer Conference Call Participants ...
Molina Healthcare press release (NYSE:MOH): Q4 Non-GAAP EPS of $2.88 beats by $0.12. Revenue of $7.41B (+41.4% Y/Y) beats by $220M. The Company issued its full year 2022 earnings guidance with premium revenue of approximately $28.5 billion and 26% adjusted EPS growth to no less than $17.00 pe...
Introduces Full Year 2022 Earnings Guidance Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today reported fourth quarter 2021 GAAP earnings per diluted share of $1.74 and adjusted earnings per diluted share of $2.88. The Company also reported full year 202...
Jazz Pharmaceuticals faces increased competition after a competitor was able to manufacture a generic version of their Narcolepsy drug Xyrem. The market for Narcolepsy, which is Jazz Pharm’s best-performing drug market, has a stable yet extremely slow growth rate. The compa...
Molina Healthcare, Inc. (NYSE: MOH) today announced details for the release of its results for the fourth quarter and year ended December 31, 2021. Molina Healthcare will issue its earnings release for the fourth quarter and year-end 2021 after the market closes on Wednesday, Februa...
Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today announced that its acquisition of Cigna’s Texas Medicaid contracts closed on January 1, 2022. As of November 30, 2021, Cigna’s Texas Medicaid business served approximately 50,000 members. About M...
News, Short Squeeze, Breakout and More Instantly...
Reaffirms Full Year 2024 Earnings Guidance Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today reported second quarter 2024 GAAP earnings per diluted share of $5.17 and adjusted earnings per diluted share of $5.86. Financial results are summarized below: Quarte...
2024-07-24 09:00:11 ET David Windley from Jefferies issued a price target of $297.00 for MOH on 2024-07-24 08:07:00. The adjusted price target was set to $297.00. At the time of the announcement, MOH was trading at $286.9. The overall price target consensus is at $359.38...
A look at the top 10 most actives in the United States SunPower Corporation (SPWR) rose 31.3% to $0.9396 on volume of 186,118,381 shares Selina Hospitality PLC (SLNA) fell 29.7% to $0.026 on volume of 168,426,091 shares NVIDIA Corporation (NVDA) fell 0.8% to $122.59 on volume of 168,211,0...